Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 25 of 129

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failureMIB298
Social work with adults experiencing complex needsNG216
Endoanchoring systems in endovascular aortic aneurysm repairIPG725
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritisIPG726
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Romosozumab for treating severe osteoporosisTA791
Sleepio to treat insomnia and insomnia symptomsMTG70
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeIPG724
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
Vaccine uptake in the general populationNG218
Vaccine uptake in under 19sQS145
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295
Granulox for managing chronic non-healing woundsMIB296
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Liposuction for chronic lymphoedemaIPG723
Epilepsies in children, young people and adultsNG217
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Intramedullary distraction for upper limb lengtheningIPG722

Results per page

  1. 10
  2. 25
  3. 50
  4. All